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Abstract Interferon-c (IFN-c) is a key molecule of T
helper 1 (Th1)-immune response against tuberculosis (TB),
and rare genetic defects of IFN-c receptors cause dissemi-
nated mycobacterial infection. The aim of the present study
was to investigate whether genetic polymorphisms found in
the Th1-immune response genes play a role in TB. In our
study, DNA samples were collected from two series of cases
including 832 patients with new smear-positive TB and 506
unrelated individuals with no history of TB in the general
populationofHanoi,Vietnam.Allelesofeightmicrosatellite
markerslocatedaroundTh1-immuneresponse-relatedgenes
and single nucleotide polymorphisms near the promising
microsatellites were genotyped. A set of polymorphisms
within the interferon gamma receptor 2 gene (IFNGR2)
showed a signiﬁcant association with protection against TB
(P = 0.00054). Resistant alleles tend to be less frequently
found in younger age at diagnosis (P = 0.011). Luciferase
assays revealed high transcriptional activity of the promoter
segment in linkage disequilibrium with resistant alleles. We
conclude that the polymorphisms of IFNGR2 may confer
resistance to the TB development of newly infected indi-
viduals.ContributionofthegeneticfactorstoTBappearedto
be different depending on age at diagnosis.
Introduction
Tuberculosis (TB) remains one of the major health prob-
lems worldwide (Lopez et al. 2006): According to an
estimate, approximately one-third of the world’s popula-
tion is infected with Mycobacterium tuberculosis (M.
tuberculosis), and more than 9 million people develop
active TB disease every year. Of these patients, 80% are
from 22 high-burden countries including Vietnam (World
Health Organization 2010).
Development of TB has been considered to be a two-
stage process, infection with M. tuberculosis and progres-
sion to disease. In total, 5–10% of immunocompetent
individuals initially infected with M. tuberculosis develop
active TB during their lifetime (Frieden et al. 2003). When
young vulnerable individuals fail to inhibit growth of the
pathogen, they often develop the disease within 2 years of
infection. In the remaining individuals, containment of
M. tuberculosis is successful, though the agent is not
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DOI 10.1007/s00439-011-1112-8eliminated completely, which leads to life-long latent
infection (Russell 2007). When immune levels are
impaired after years of infection, reactivation of dormant
bacteria leads to disease manifestation, which contributes
to the development of elderly TB, though new TB patients
affected by re-infection also have to be taken into account
(Tufariello et al. 2003). Protective immunity to control the
initial infection, orchestrated by immune cells including T
cells and macrophages, is inﬂuenced by a variety of factors
including genetic predisposition (Mo ¨ller et al. 2010a).
T helper 1 (Th1)-type immune system is crucial to
protection against mycobacterial diseases, in which inter-
feron-c (IFN-c) has a key role (Lin and Flynn 2010).
Although T cell response to mycobacterial infection in
human beings is difﬁcult to be addressed experimentally
(Cooper 2009), it is known that genetic defects of Th1
molecules can be found in genes such as interferon gamma
receptor 1 (IFNGR1), interferon gamma receptor 2
(IFNGR2), signal transducer and activator of transcription
1, 91 kDa (STAT1), interleukin 12B (IL12B) and interleu-
kin 12 receptor, beta 1 (IL12RB1) cause severe mycobac-
terial diseases (Zhang et al. 2008). These observations have
highlighted IFN-c/interleukin-12 (IL-12) axis and their
polymorphisms have been investigated in mycobacterial
infection: association of promoter polymorphism in
IFNGR1 with TB was reported in African populations in
independent studies, whereas association of IFNGR2 with
TB has not been published in the literature (Cooke et al.
2006; Stein et al. 2007). Associations with IL12B and
IL12RB1 were not consistently shown (Mo ¨ller et al.
2010b). In the present study, we analyzed genetic poly-
morphisms of major Th1 cytokine receptors (IFNGR1,
IFNGR2, IL12RB1 and IL12RB2) and signal transduction
molecules (STAT1 and STAT4) in Hanoi–Vietnamese and
reported a disease association and functional signiﬁcance
of polymorphisms in IFNGR2.
Materials and methods
Study population
The patients and control subjects were recruited in Hanoi,
Vietnam (Horie et al. 2007). In total, 832 smear-positive
pulmonary TB patients without previous episodes of TB
(age 41 ± 14.4, males 77.6%) and 506 healthy volunteers
without previous and present history of TB (age
37 ± 10.3, males 50.0%) participated in this study. All of
them were unrelated Hanoi, Vietnamese. TB patients were
all recruited immediately after the diagnosis was made.
The TB panel A (n=277, age 41 ± 13.5, males 73.3%)
was collected in 2003–2004, and the second TB panel B
(n=555, age 41 ± 14.8, males 79.8%) was collected in
2007–2009. Pulmonary physicians diagnosed all the
patients as new active pulmonary TB and treated them
with anti-TB drugs based on the guidelines of the national
TB program. Informed consent was obtained from all
participants. The study protocol was approved by the
ethics committees of the Ministry of Health, Vietnam and
the National Center for Global Health and Medicine,
Japan. Since 4 patients in panel A were human immuno-
deﬁciency virus (HIV) positive by previously described
PCR assay (Panteleeff et al. 1999) with minor modiﬁca-
tions and 49 patients in panel B were HIV seropositive
(Hang et al. 2011), they were excluded from further
analysis.
Microsatellite markers
We used eight microsatellite markers (IFNGR1-MS1,
IFNGR2-MS1, IFNGR2-MS2, IL12RB1-MS1, IL12RB2-
MS1, IL12RB2-MS2, STAT1-MS1 and STAT4-MS1) loca-
ted in the major Th1-immune response genes (Tanaka et al.
2005) for screening of genetic polymorphisms associated
with active TB. A part of the samples, 98 TB patients from
the TB panel A and 200 controls were analyzed as
described under (Tanaka et al. 2005).
Single nucleotide polymorphisms (SNP) screening
in IFNGR2 of Vietnamese samples
Forty-eight control samples were subjected to PCR ampli-
ﬁcationsofpromoterandsevenexonregionsofIFNGR2and
their sequences were analyzed for polymorphisms. GC
content of genomic sequence upstream of the translation
initiation codon was high (78.2% of nucleotides -1t o
-500), and PCR condition was optimized for GC-rich tem-
plate. The genomic DNA was extracted from anticoagulated
blood with QIAamp DNA midi kit (QIAGEN, Hamburg,
Germany). PCR was performed using TaKaRa LA Taq with
GC buffer I (TaKaRa, Shiga, Japan) with primers 50-CTCC
CAACAGGCGTCAAACGACATGGTG-30 and50-TGGTC
CCTGCTCCACCGCTGCTACTACAAA-30. PCR cycling
condition was 40 cycles of 95C for 30 s, 67C for 30 s and
72Cfor2 min.Ampliﬁedproducts(1,607 bp)werepuriﬁed
and sequenced with BigDye Terminator v3.1 Cycle
Sequencing Kit (Applied Biosystems, Foster City, CA,
USA) using 3100 Genetic Analyzer (Applied Biosystems),
with primers 50-AGCTTAATATGTACTTTGGGG-30 and
50-CACCCACTCTGAGCACCCGG-30. This method was
also used for the typing of three promoter SNPs, rs8134145,
rs8126756 and rs17882748. Sequencing primers that have
the allelic variant at their 30-end 50-GGAGGGGTGGGGGC
TCCAGGGAAA-30,5 0-GCAGGGCCCGCCTCTTCCCGA
GCA-30 and50-GGGCTCCAGGGAAAGCCCGGGGGT-30
were also designed, and allele-speciﬁc sequencing was
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123performed to directly determine the haplotypes of the three
promoter SNPs.
Selection of representative SNPs around IFNGR2
and genotyping
Representative SNPs around IFNGR2 were selected from
HapMap database (The International HapMap Consortium
2005). SNP genotype data of Han Chinese in Beijing
(CHB) encompassing 350 kb from IL10RB to CRYZL1
were analyzed by Haploview 4.2 (Barrett et al. 2005), and
27 representative SNPs were chosen based on the method
of block-by-block tags in linkage disequilibrium (LD)
blocks determined by conﬁdence interval method (Gabriel
et al. 2002). The IFNGR2 SNPs identiﬁed as mentioned
above and selected SNPs were genotyped in 273 TB
patients of panel A and 506 controls. Genotyping was
performed by the Digitag2 assay that has previously been
described in another study (Nishida et al. 2007).
Rapid ampliﬁcation of cDNA end (50-RACE)
of IFNGR2
The exact 50 end of exon 1 was conﬁrmed with FirstChoice
RLM-RACE Kit (Ambion, Austin, TX, USA) using total
RNA of THP-1 cells (ATCC TIB-202) stimulated with
10 ng/ml of phorbol myristate acetate (Schwende et al.
1996), U937 cells (ATCC CRL-1593.2) and Jurkat cells
(ATCC TIB-152).
Luciferase assay
Promoter region of IFNGR2 (Rhee et al. 1996) consisting of
1,167 bp (position -1,172 to -6 of initiation codon) was
ampliﬁed by PCR and inserted into Xho I and Bgl II sites of
pGL4.10 vector (Promega, Madison, WI, USA). Three
plasmids of the observed haplotypes (CCC, ATC, ATT of
rs8134145, rs8126756 and rs17882748) were constructed,
and their sequences were conﬁrmed to be devoid of any
additional nucleotide difference. Reporter plasmids were
mixed with pRL-TK (Promega) and transfected to Jurkat
human T-cell leukemia cells with Lipofectamin LTX
(Invitrogen, Carlsbad, CA, USA) in triplicate. Cells were
harvested after 24 h and luciferase activity was measured
using Dual-Luciferase Reporter Assay System (Promega).
The transfection experiments were repeated twice with
three independent subclones of each plasmid.
Statistical analysis
Disease associations with markers were assessed by Chi-
square test or Fisher’s exact test, and P values less than
0.05 were considered signiﬁcant. Statistical analysis was
performed using Stata version 10 (StataCorp, College
Station, TX, USA). When necessary, P values were sub-
jected to Bonferroni’s correction for multiple comparisons.
To determine whether genotype frequencies in the popu-
lations are compatible with Hardy–Weinberg equilibrium,
Hardy–Weinberg exact tests were carried out using the
program Arlequin version 3.11 (Excofﬁer et al. 2007). To
assess pairwise LD between polymorphisms, we calculated
Lewontin’s D0 and r square (r
2) for polymorphisms by
Haploview version 4.2 (Barrett et al. 2005). TB disease
associated with genetic variations was assessed by odds
ratios unadjusted or adjusted for sex, age at recruitment and
its interaction using logistic models. Tendency of having
resistant alleles in the order of age at diagnosis was also
tested using a similar logistic model within the TB group.
Difference in luciferase activity between the haplotype
under consideration and the other haplotypes was assessed
by Wilcoxon rank sum/Mann–Whitney U test.
Results
Microsatellite markers
Microsatellite marker IFNGR2-MS1 located in 50-upstream
region of IFNGR2 showed signiﬁcant association with TB
even after Bonferroni’s correction (Table 1) and the fre-
quency of IFNGR2-MS1-325 allele was signiﬁcantly lower
in TB patients than in controls (Supplementary table 1).
IFNGR2-MS2, the other microsatellite was located in
intron 2 of IFNGR2 and the frequency of IFNGR2-MS2-
252 allele was also lower in TB patients than in controls
(uncorrected P = 0.0024), but not signiﬁcant after
Bonferroni’s correction. IFNGR2-MS1-325 allele and
IFNGR2-MS2-252allelewereinLD(D0 = 0.91,r
2 = 0.64).
Screening of genetic polymorphisms in IFNGR2
Forty-eight control samples were subjected to PCR
ampliﬁcations of promoter and seven exons of IFNGR2 and
their sequences were analyzed for possible polymorphisms.
In the exonic sequences of IFNGR2, a non-synonymous
SNP, rs9808753 was found in exon 2, and another SNP,
rs1059293 was shown in 30-untranslated region (UTR) of
exon 7, while there were no SNPs in exon–intron bound-
aries. In the 50 region up to -850 bp of the translation
initiation codon, three SNPs, rs8134145, rs8126756 and
rs17882748 were also identiﬁed.
Genotyping of selected SNPs around IFNGR2
Association of microsatellite markers of IFNGR2 with TB
prompted us to identify relevant SNPs that may show
Hum Genet (2012) 131:675–682 677
123further association. We genotyped 27 SNPs selected
around IFNGR2, 3 SNPs in the 50 upstream region, a non-
synonymous SNP in exon 2, and a 30UTR SNP in exon 7 of
IFNGR2 in 273 TB patients (panel A) and 506 controls
(Fig. 1, Supplementary table 2). The rs2834213 SNP in
intron 2 and the rs1059293 SNP in 30UTR were associated
with TB (P = 0.0073, OR 0.69 95% conﬁdence interval
[CI] 0.52–0.91; P = 0.0088, OR 0.70 95% CI 0.54–0.92).
These SNPs were in Hardy–Weinberg equilibrium in the
control group. We conﬁrmed that SNPs in other nearby
genes were not associated with the disease (Supplementary
table 2). As expected, the resistant G allele of rs2834213
and C allele of rs1059293 were both in LD with IFNGR2-
MS1-325 allele and IFNGR2-MS2-252 allele (Supple-
mentary Fig. 1). Particularly, the resistant G allele of
rs2834213 in intron 2 was in high LD with IFNGR2-MS1-
325 allele (D0 = 0.94, r
2 = 0.83), that is located 1.9 kb
upstream of the translation initiation codon.
Directly determined haplotypes consisting of three
SNPs in the 50 GC-rich region of IFNGR2
In addition to single SNPs associated with the disease, we
also characterized a set of SNPs in the 50 GC-rich region of
Table 1 Association results for microsatellite markers
Marker Locus No. of alleles No. of alleles P value
b Minimum P
value
b (2 9 2)
P value
c P value
(total) (\5% grouped
a)( 2 9 m) Corrected HWE
IFNGR1-MS1 6q23.3 14 7 0.419 0.0549 NS 0.4858
IFNGR2-MS1 21q22.11 8 5 0.016 0.0009 0.036 0.2762
IFNGR2-MS2 6 4 0.013 0.0024 NS 0.0326
IL12RB1-MS1 19p13.1 4 4 0.366 0.1600 NS 0.1606
IL12RB2-MS1 1p31.3-p31.2 12 6 0.155 0.0267 NS 0.7499
IL12RB2-MS2 6 4 0.540 0.2228 NS 0.7289
STAT1-MS1 2q32.2 13 5 0.563 0.3010 NS 0.0254
STAT4-MS1 2q32.2-q32.3 11 5 0.232 0.1046 NS 0.5243
NS not signiﬁcant, HWE Hardy–Weinberg equilibrium
a Alleles with frequencies less than 5% were grouped
b Fisher’s exact test
c Bonferroni’s correction. 2 9 2 minimum P value was multiplied by the numbers of total alleles (40)
Fig. 1 Association P values
and pairwise LD of genotyped
polymorphisms around IFNGR2
region. a Association results for
32 SNPs in 273 patients (panel
A) and 506 controls are shown.
P values of microsatellite
markers in 98 patients and 200
controls are also included.
Positions of genes are shown on
the top. b Pairwise LD (r
2)
between 32 SNPs and 2
microsatellite markers
determined by the Haploview
program is shown. In the
calculation of pairwise LD,
microsatellite alleles except for
one showing the smallest
P value were grouped, and the
microsatellite locus was
regarded as having only two
alleles
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123the gene, rs8134145, rs8126756 and rs17882748, since
these three SNPs are closely located within 300 bp
upstream of the transcription start site as discussed below,
which may inﬂuence IFNGR2 expression. When we
directly determined haplotypes of three 50 SNPs by allele-
speciﬁc sequencing in 273 patients and in 506 controls,
three common haplotypes (CCC, ATC and ATT) accoun-
ted for 99.7% of chromosomes. The haplotype ATC was in
high LD with the intron 2 SNP rs2834213 (D0 = 0.97,
r
2 = 0.82), and frequencies of the ATC haplotype were
signiﬁcantly lower in patients than in controls (P = 0.036,
OR 0.76 95% CI 0.58–0.99). Haplotypes carrying SNPs in
the entire IFNGR2 region and their frequencies were esti-
mated in 273 patients and in 506 controls. Consequently,
the G allele of the intron 2 SNP rs2834213, the C allele of
the 30UTR SNP rs1059293 and the directly determined
haplotype ATC, are uniquely contained in the same hap-
lotype as shown in Supplementary table 3.
Transcription start site (TSS) of IFNGR2
In the public database, the aforementioned 50 SNPs,
rs8134145, rs8126756, and rs17882748 are regarded as
variants in 50 UTR, since TSS of the reference cDNA
sequence (NM_005534.3) is located at position -648 of
the translation initiation codon. However, multiple TSS
were actually reported in IFNGR2, the positions of which
were distributed from the initiation codon to almost 990 bp
upstream, presumably due to cell type differences (Rhee
et al. 1996). For this reason, we determined the 50 ends by
50 RACE in our study. As a result, TSS obtained from all
immune cell lines tested were 121 bp upstream of the
initiation codon. Thus, the positions of the three SNPs were
calculated as -295, -285 and -8 from the TSS, indicating
that they are promoter variants in these cell types.
Association results of TB panel B
We selected the intron 2 SNP, rs2834213 as a representa-
tive SNP for the disease-resistant polymorphisms and
genotyped 503 patients in TB panel B, which were com-
pared with the original control subjects (N = 506) in
Table 2. The G allele of rs2834213 was signiﬁcantly
associated with TB in panel B (P = 0.0025, OR 0.71 95%
CI 0.57–0.89). In a logistic model to assess possible con-
founders, adjusted odds ratios was compared with non-
adjusted odds ratios for the G allele, which were hardly
affected by sex, age at recruitment and its interaction term,
indicating that the IFNGR2 SNP remained signiﬁcantly
associated with TB in dominant and recessive models
respectively (P = 0.016 and P = 0.004; table not shown).
Furthermore, we set up another logistic model to
examine the relationship between having the TB-resistant
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123G alleles (as binary outcome) and age at diagnosis (as a
continuous variable). In patients from panel A and B
(n = 757), the TB-resistant G allele was less frequently
found, as the age at diagnosis was younger (P = 0.011).
Similarly, in the age-stratiﬁed analysis, when the patients
are 10 years younger at the time of diagnosis, the odds ratio
(OR) for having the G allele was 0.88 (95% CI, 0.79–0.98)
and this trend remained signiﬁcant (P = 0.019) (Table 3).
Luciferase assay
We constructed plasmids containing 50 fragments in which
only nucleotide sequences of the three promoter SNPs
rs8134145, rs8126756, and rs17882748 are different and
measured transcriptional activity of the three promoter
segments (CCC, ATC, and ATT) in Jurkat human T-cell
leukemia cells. Consequently, the resistant ATC haplotype
had signiﬁcantly higher transcriptional activity than CCC
haplotype and ATT haplotype (P = 0.037 respectively) by
Mann–Whitney U test (Fig. 2).
Discussion
IFN-c plays a crucial role in host defense against intra-
cellular pathogens mainly through activation of macro-
phages and regulation of Th1 cell response (Boehm et al.
1997). IL-12 released from dendritic cells and macro-
phages drives production of IFN-c via IL-12 receptors,
IL12RB1 and IL12RB2, on Th1 cells and subsequent
activation of STAT4. In turn, IFN-c binds to IFN-c
receptors composed of IFNGR1 and IFNGR2 subunits and
transduces STAT1 signals to target cells (Bach et al. 1997).
In this study, we ﬁrst screened eight microsatellite
markers within the genes encoding these Th1 cytokine
receptors and signal transducers, and demonstrated that the
IFNGR2 marker alleles showed signiﬁcant association with
active TB. SNPs around the gene were analyzed and a
strong disease association with the intron 2 SNP
rs2834213, the 30UTR SNP rs1059293 and the 50 promoter
segment characterized by three SNPs was thus demon-
strated. Possible inﬂuence of population substructure was
kept to a minimum, since their ethnicity was Hanoi Viet-
namese in which more than 99% were the Kinh people
(Hoa et al. 2008).
To our knowledge, this is the ﬁrst report of IFNGR2
polymorphisms associated with TB. Intron 2 SNP,
rs2834213 was most robustly associated with TB, but its
biological importance is currently unclear. Indeed, it was
not located near the splice sites (5,582 nucleotides down-
stream of splice donor site and 877 nucleotides upstream of
splice acceptor site). A SNP in 30UTR of exon 7 rs1059293
was in strong LD with the rs2834213 and also associated
with TB, but it was 99 nucleotides upstream of polyade-
nylation signal. IFNGR2 did not carry any non-synony-
mous SNP in high LD with rs2834213.
In an attempt to search functional polymorphism(s) in
strong LD with the intron SNP (rs2834213) further, we
identiﬁed the 300 bp promoter segment containing three
SNPs. HapMap database does not have data of the three
promoter SNPs, presumably due to high GC content that
hinders high throughput genotyping method. The direct
haplotyping revealed that it was also associated with the
disease as well as the intron 2 SNP. Although we demon-
strated that the promoter ATC haplotype showing an
inverse disease association has high transcriptional activity
in vitro and may confer resistance to TB, we could not
Table 3 Tendency of having G allele (rs2834213) in the order of age
strata at the time of diagnosis (N = 757)
Age at
diagnosis
(year)
GA or GG
genotype (n/N)
(%) Odds ratio per 10-year
change* (95% CI)
16–25 35/124 28.2 0.88 (0.79–0.98)
26–35 43/171 25.1
36–45 53/165 32.1
46–55 54/171 31.6
56–65 35/87 40.2
65– 15/39 38.5
* In a logistic model, the trend of having the G allele was calculated
as odds ratio when the patients are 10-years younger at the time of
diagnosis (P = 0.019) Fig. 2 Dual luciferase reporter assays. The ratios of Fireﬂy luciferase
activity (signal S) to Renilla luciferase activity (control C) are
displayed using box and whisker plots. Three subcloned plasmids
were prepared, and each subcloned plasmid was tested in triplicate
and S/C values were averaged. The experiments were carried out
twice independently. As a result, six independent S/C values were
obtained for each haplotype. ATC haplotype showed signiﬁcantly
higher transcriptional activity than CCC haplotype and ATT haplo-
type (*, **P = 0.037, respectively) by Mann–Whitney U test. No
signiﬁcant difference was observed between CCC and ATT haplo-
types (data not shown)
680 Hum Genet (2012) 131:675–682
123conclude which polymorphism around IFNGR2 is primar-
ily responsible for the disease until the functional roles of
other SNPs showing more robust association are fully
studied.
Among previous TB association studies with Th1-rela-
ted genes, CC genotype at the -56 C/T SNP (rs2234711) of
IFNGR1 was repeatedly associated with TB in African
populations (Cooke et al. 2006; Stein et al. 2007). In our
study, IFNGR1-MS1-158 allele was in strong LD with -56
SNP (Tanaka et al. 2005), but this IFNGR1 marker allele
was not associated with TB. The lack of association is
presumably because of insufﬁcient power to detect weak
genetic effects. Otherwise, it could be due to population-
speciﬁc LD, when the true causative variant was not -56
SNP itself.
Experimental data have shown that IFNGR2 is a key
regulator for IFN-c-STAT1 signaling in T cells (Schroder
et al. 2004; Regis et al. 2006). During the development of
Th1 cells, IFNGR2 transcription is reduced in the IFN-c
rich condition and this reduction alleviates a potentially
harmful anti-proliferative action of IFN-c-STAT1 signal-
ing. However, IFNGR2 expression is not completely sup-
pressed, because temporary activation of STAT1 is still
necessary for Th1 system. IFNGR2 transcription is thus
ﬁne-tuned during the Th1 differentiation process. In the
promoter region, the transcriptional activity of the resistant
haplotype ATC was higher than the other two common
haplotypes in the Jurkat T cell line at baseline levels.
Although physiological modulation of IFNGR2 expression
is not easily simulated in a single cell-type model, this
segment may have a potential to inﬂuence Th1 function
through IFNGR2 regulation.
In this study, another interesting ﬁnding is that the
resistant allele tend to be less frequently observed in
younger patients at the time of diagnosis, a surrogate for
age at onset in new patients. This effect was moderate but
signiﬁcant. The allele frequency in older age at diagnosis
nearly reached the level of the control population. It is
likely that the elderly kept latent infection of M. tuber-
culosis for long years, and the age-associated decline in
immune response caused development of active TB, while
the younger patients developed active TB soon after ini-
tial infection (Tufariello et al. 2003). In intermediate or
low burden countries, there are more elderly patients and
the effect of the resistant allele of IFNGR2 may be
smaller.
Moreover, in African countries with high rates of TB
and HIV co-infection, HIV is the strongest risk factor for
TB development (Reid et al. 2006). By contrast, the
proportion of HIV-positive TB patients is only 8.8% in
the Vietnamese TB panel B and 1.4% in TB panel A,
therefore possible effect of the resistant allele on HIV
infection could not be determined in this study. In the
previous reports, other polymorphisms of IFNGR2 were
associated with liver ﬁbrosis of chronic hepatitis C virus
infection and with viremia of hepatitis B virus infection
(Nalpas et al. 2010; Huang et al. 2011). Because IFN-c is
a key cytokine for the control of infectious diseases,
association of IFNGR2 polymorphisms with HIV infec-
tion needs be clariﬁed.
One limitation in our study is a single control panel of
the Vietnamese population. Results of the ﬁrst case–control
set were only partially conﬁrmed because of incomplete
independence of the two study sets, though sample size
itself was not small. Another limitation is that our control
panel may include asymptomatic individuals with latent
TB infection, because performing tuberculin testing is not
common in Vietnam. Considering two-stage process of
infection with the pathogen and progression to disease, we
cannot directly specify which stage of TB was more
affected by IFNGR2 in our study population. Future use of
interferon gamma release assays to detect latent infection
of M. tuberculosis in this ﬁeld might be helpful to arrive
at a solution (Pai et al. 2008). Because of the complexity
of LD structure and the age-dependent effect as regards
these variations, carefully conducted studies should be
undertaken to reproduce our results in other populations.
Validation studies by re-sequencing are also warranted. In
non-Asian populations, however, the LD of rs2834213
does not appear to reach the promoter region of IFNGR2
(data not shown), indicating that the functional promoter
haplotype may not be easily found in disease marker
association studies by the conventional tag SNP-based
approach in other populations.
We conclude that the polymorphisms of IFNGR2 may
confer resistance to TB in Vietnam. It appeared to be dif-
ferent depending on age at diagnosis. Further functional
studies are needed to elucidate the genetic susceptibility to
TB, fully considering complicated immune process
regarding early or late onset of the disease.
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